2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
PSG Announces New Features Designed to Support Biosimilar Strategy
Dallas, TX and San Francisco, CA (August 29, 2022) Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform,…
Read Post
Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group
Specialty trend maintains double-digit growth as more specialty drugs enter market despite growing prevalence of biosimilars DALLAS, TX (August 23, 2022) – Pharmaceutical Strategies Group (PSG),…
Read Post
The Growing Importance of Member Satisfaction and Engagement in Drug Benefit Design
Drug benefit design is increasingly complex. The number of drugs on the market is growing, and decisions about program structure, cost sharing, formulary design,…
Read Post
Report finds employers are increasingly dissatisfied with high-deductible health plans
When high-deductible health plans (HDHPs) were introduced in the early 2000s, many expected a new era of healthcare consumerism. HDHPs were expected to foster…
Read Post
Trends in Drug Benefit Design Report released by Pharmaceutical Strategies Group
Results in PSG’s latest benefit design research reveal an increased focus on member satisfaction DALLAS, Tex. – New research on the latest trends in benefit design launches today.
Read Post
2022 State of Specialty Spend & Trend Report
The latest insights on specialty drug spend and trend across pharmacy and medical benefits The sixth annual State of Specialty Spend and Trend…
Read Post
PSG Position: FTC Inquiry into the Prescription Drug Middlemen Industry
At the heart of the investigation: access, pricing, and fair market competition from the six largest vertically integrated pharmacy benefit managers What it is: …
Read Post
Trends in Specialty Drug Benefit Design: Member Engagement
Employers need to strike the right balance when making decisions about specialty drug benefits. So much of the conversation around specialty drugs, understandably, tend…
Read Post
Trends in Specialty Drug Benefit Design: New to Market Formulary Blocks
New to market formulary blocks (NTMBs) are increasingly prevalent strategies pharmacy benefit managers (PBMs) are using to control specialty prescription drug costs. NTMBs bar certain newly…
Read Post
Trends in Specialty Drug Benefit Design: Rebates
Employers are navigating a fast-changing landscape of specialty drug benefits. Specialty drug patients now make up 4% of commercially insured member populations as of…
Read Post
2023 Medicare Advantage and Part D Final Rule on Pharmacy Price Concessions
The Centers for Medicare and Medicaid (CMS) published on May 9, 2022, the highly anticipated Medicare Advantage and Part D Final Rule CMS-4192-F. The…
Read Post